Industry Analysis & Industry Trends
One in six Australian couples suffers from infertility. The Fertility Clinics industry assists patients who are unable to conceive naturally through a variety of treatment options, the most common and popular of which is in-vitro fertilisation (IVF) cycles. Over the past five years, the number of completed IVF cycles in Australia has increased by 1.2% annualised to a forecast 40,800 cycles in 2014-15. A number of factors have led to growth in demand for infertility treatments and procedures, particularly from women who are choosing to have children later in life. Australia is also one of the few developed countries in the world that has substantial government funding for fertility treatments, which has made fertility treatment in Australia more economically feasible... purchase to read more
Industry Report - Industry Key Buyers Chapter
The Fertility Clinics industry is defined by a high level of market share concentration, with the three largest operators alone accounting for over 80% of industry revenue in 2014-15. This reflects the dominance of Virtus Health, Monash IVF Group and Genea who combined account for roughly 70% of all assisted reproductive treatments.
There has been a trend towards increasing market concentration due to the amount of consolidation occurring as a result of mergers and acquisitions. However, establishment numbers are expected to increase over the next five years as companies continue expanding. The industry is in a growth life cycle phase because it is relatively young. Participation in industry services is increasing as people become more aware of the benefits of IVF... purchase to read more